Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IMAX CORPIMAX · Entity 4276 | Director · Chief Executive Officer | August 18, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IMAX CORP
Report date August 18, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common sharesSEC Table I · non-derivative | Direct | 665,002 |
Ending reported balance
After 2026-08-20 transaction · row 6
5 source rows · reconciled sequenceRow 2 · 2026-08-18 · Conversion · Acquired 151,253 · Balance 916,255 F1: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Row 3 · 2026-08-18 · Sale · Disposed 151,253 · Balance 765,002 F2: Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Row 4 · 2026-08-19 · Conversion · Acquired 205,504 · Balance 970,506 F1: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Row 5 · 2026-08-19 · Sale · Disposed 205,504 · Balance 765,002 F2: Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Row 6 · 2026-08-20 · Sale · Disposed 100,000 · Balance 665,002 |
| stock options (to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.90 · Expires 2027-01-03 | Direct | 1,181,158 |
Reported balance
After 2026-08-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-18 · Conversion · Disposed 151,253 · Balance 1,181,158 F3: These options were issued in 2017 and are set to expire on January 3, 2027. F4: The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019. F5: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively. |
| stock options (to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.90 · Expires 2027-01-03 | Direct | 975,654 |
Reported balance
After 2026-08-19 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-19 · Conversion · Disposed 205,504 · Balance 975,654 F3: These options were issued in 2017 and are set to expire on January 3, 2027. F4: The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019. F5: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively. |
| common shares (opening balance)SEC Table I · non-derivative | Direct | 765,002 |
Reported balance
Holding disclosure · report date 2026-08-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 765,002 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026.
F2: Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026.
F3: These options were issued in 2017 and are set to expire on January 3, 2027.
F4: The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019.
F5: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Aug 20, 2026 21:37 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 100,000 | $53.23 | $5,323,370.00 |
DisclosureSEC source: 0001214659-26-010664 · marketforms-73792.xml · nonDerivative · entry 6 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 665,002 Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 21:37 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 205,504 | $31.90 Strike: $31.90 | $6,555,577.60 |
DisclosureSEC source: 0001214659-26-010664 · marketforms-73792.xml · derivative · entry 8 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 975,654 Underlying: common shares · 205,504 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These options were issued in 2017 and are set to expire on January 3, 2027. F4 · derivative.exercise_date: The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019. F5 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 21:37 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 205,504 | $53.27 | $10,946,293.86 |
DisclosureSEC source: 0001214659-26-010664 · marketforms-73792.xml · nonDerivative · entry 5 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 F2 · shares: Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 21:37 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 205,504 | $31.90 | $6,555,577.60 |
DisclosureSEC source: 0001214659-26-010664 · marketforms-73792.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 970,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 21:37 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 151,253 | $31.90 Strike: $31.90 | $4,824,970.70 |
DisclosureSEC source: 0001214659-26-010664 · marketforms-73792.xml · derivative · entry 7 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,181,158 Underlying: common shares · 151,253 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These options were issued in 2017 and are set to expire on January 3, 2027. F4 · derivative.exercise_date: The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019. F5 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 21:37 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 151,253 | $51.00 | $7,714,644.14 |
DisclosureSEC source: 0001214659-26-010664 · marketforms-73792.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 F2 · shares: Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 21:37 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 151,253 | $31.90 | $4,824,970.70 |
DisclosureSEC source: 0001214659-26-010664 · marketforms-73792.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 916,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Read SEC document |
| April 27, 2026 Filed Apr 28, 2026 20:15 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 8,943 | $31.40 Strike: $31.40 | $280,810.20 |
DisclosureSEC source: 0001214659-26-005177 · marketforms-73021.xml · derivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,332,411 Underlying: common shares · 8,943 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,332,411, 231,562 and 765,002, respectively. Read SEC document |
| April 27, 2026 Filed Apr 28, 2026 20:15 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 8,943 | $37.33 | $333,814.47 |
DisclosureSEC source: 0001214659-26-005177 · marketforms-73021.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 27, 2026 Filed Apr 28, 2026 20:15 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 8,943 | $31.40 | $280,810.20 |
DisclosureSEC source: 0001214659-26-005177 · marketforms-73021.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 773,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Effective April 27, 2026, the sales under the 10b5-1 plan are complete. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:46 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 34,182 | $31.40 Strike: $31.40 | $1,073,314.80 |
DisclosureSEC source: 0001214659-26-004849 · marketforms-72952.xml · derivative · entry 7 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,341,354 Underlying: common shares · 34,182 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,341,354, 231,562 and 765,002, respectively. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:46 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 34,182 | $37.06 | $1,266,689.21 |
DisclosureSEC source: 0001214659-26-004849 · marketforms-72952.xml · nonDerivative · entry 5 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:46 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 34,182 | $31.40 | $1,073,314.80 |
DisclosureSEC source: 0001214659-26-004849 · marketforms-72952.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 799,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:46 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 41,737 | $31.40 Strike: $31.40 | $1,310,541.80 |
DisclosureSEC source: 0001214659-26-004849 · marketforms-72952.xml · derivative · entry 6 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,375,536 Underlying: common shares · 41,737 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,341,354, 231,562 and 765,002, respectively. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:46 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 41,737 | $37.05 | $1,546,339.16 |
DisclosureSEC source: 0001214659-26-004849 · marketforms-72952.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:46 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 41,737 | $31.40 | $1,310,541.80 |
DisclosureSEC source: 0001214659-26-004849 · marketforms-72952.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 806,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 15,746 | $31.40 Strike: $31.40 | $494,424.40 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · derivative · entry 10 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,417,273 Underlying: common shares · 15,746 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,417,273, 231,562 and 765,002, respectively. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 15,746 | $37.07 | $583,715.24 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · nonDerivative · entry 7 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 15,746 | $31.40 | $494,424.40 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · nonDerivative · entry 6 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 780,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 6,924 | $31.40 Strike: $31.40 | $217,413.60 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · derivative · entry 9 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,433,019 Underlying: common shares · 6,924 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,417,273, 231,562 and 765,002, respectively. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 6,924 | $37.07 | $256,657.45 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · nonDerivative · entry 5 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 6,924 | $31.40 | $217,413.60 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 771,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 97,462 | $31.40 Strike: $31.40 | $3,060,306.80 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · derivative · entry 8 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,439,943 Underlying: common shares · 97,462 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,417,273, 231,562 and 765,002, respectively. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 97,462 | $37.15 | $3,620,966.70 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 22:08 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 97,462 | $31.40 | $3,060,306.80 |
DisclosureSEC source: 0001214659-26-004708 · marketforms-72937.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 862,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Read SEC document |
| April 10, 2026 Filed Apr 10, 2026 22:29 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 135,046 | $31.40 Strike: $31.40 | $4,240,444.40 |
DisclosureSEC source: 0001214659-26-004558 · marketforms-72930.xml · derivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,537,045 Underlying: common shares · 135,046 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,537,045, 231,562 and 765,002, respectively. Read SEC document |
| April 10, 2026 Filed Apr 10, 2026 22:29 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 135,046 | $37.82 | $5,106,872.53 |
DisclosureSEC source: 0001214659-26-004558 · marketforms-72930.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 10, 2026 Filed Apr 10, 2026 22:29 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 135,046 | $31.40 | $4,240,444.40 |
DisclosureSEC source: 0001214659-26-004558 · marketforms-72930.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 900,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Read SEC document |
| April 06, 2026 Filed Apr 6, 2026 21:58 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 12,987 | $31.40 Strike: $31.40 | $407,791.80 |
DisclosureSEC source: 0001214659-26-004375 · marketforms-72897.xml · derivative · entry 7 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,672,451 Underlying: common shares · 12,987 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,672,451, 231,562 and 765,002, respectively. Read SEC document |
| April 06, 2026 Filed Apr 6, 2026 21:58 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 12,987 | $40.26 | $522,883.89 |
DisclosureSEC source: 0001214659-26-004375 · marketforms-72897.xml · nonDerivative · entry 5 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 06, 2026 Filed Apr 6, 2026 21:58 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 12,987 | $31.40 | $407,791.80 |
DisclosureSEC source: 0001214659-26-004375 · marketforms-72897.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 777,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 21:58 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 12,037 | $31.40 Strike: $31.40 | $377,961.80 |
DisclosureSEC source: 0001214659-26-004375 · marketforms-72897.xml · derivative · entry 6 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,685,438 Underlying: common shares · 12,037 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,672,451, 231,562 and 765,002, respectively. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 21:58 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 12,037 | $40.00 | $481,520.93 |
DisclosureSEC source: 0001214659-26-004375 · marketforms-72897.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 21:58 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 12,037 | $31.40 | $377,961.80 |
DisclosureSEC source: 0001214659-26-004375 · marketforms-72897.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 777,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:35 UTC | IMAX CORP IMAX · Entity 4276 | Conversionstock options (to buy) · Derivative | 121,220 | $31.40 Strike: $31.40 | $3,806,308.00 |
DisclosureSEC source: 0001214659-26-003226 · marketforms-72488.xml · derivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,064 Underlying: common shares · 121,220 shares Expires 2026-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These options were issued in 2016 and are set to expire on June 7, 2026. F3 · derivative.exercise_date: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,697,475, 231,562 and 765,002, respectively. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:35 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 121,220 | $40.10 | $4,860,837.15 |
DisclosureSEC source: 0001214659-26-003226 · marketforms-72488.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 765,002 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:35 UTC | IMAX CORP IMAX · Entity 4276 | Conversioncommon shares | 121,220 | $31.40 | $3,806,308.00 |
DisclosureSEC source: 0001214659-26-003226 · marketforms-72488.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 886,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2026. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 21:00 UTC | IMAX CORP IMAX · Entity 4276 | Tax withholdingcommon shares | 159,670 | $40.80 | $6,514,536.00 |
DisclosureSEC source: 0001214659-26-003100 · marketforms-72109.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 765,002 F3 · shares: Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the performance stock units. F4 · balance_after: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695, 231,562 and 765,002, respectively. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 21:00 UTC | IMAX CORP IMAX · Entity 4276 | Grantcommon shares | 91,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-003100 · marketforms-72109.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 924,672 F2 · shares: Represents the conversion of vested performance stock units into common shares granted by the Company on January 2, 2023. The shares earned are based on the level of achievement on the TSR performance conditions over the three-year performance period. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 21:00 UTC | IMAX CORP IMAX · Entity 4276 | Grantcommon shares | 196,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-003100 · marketforms-72109.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 832,904 F1 · shares: Represents the conversion of vested performance stock units into common shares granted by the Company on January 2, 2023. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three-year performance period. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Grantrestricted share units · Derivative | 97,357 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · derivative · entry 11 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,357 Underlying: common shares · 97,357 shares Expires not disclosed F3 · security: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F4 · derivative.exercise_price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F4 · price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F8 · derivative.exercise_date: The restricted share units vest and will be converted to common shares in three installments: 32,452 on each of January 2, 2027, January 2, 2028 and 32,453 January 2, 2029. F8 · derivative.expiration_date: The restricted share units vest and will be converted to common shares in three installments: 32,452 on each of January 2, 2027, January 2, 2028 and 32,453 January 2, 2029. F9 · balance_after: This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 231,562 and 635,940 respectively. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversionrestricted share units · Derivative | 36,506 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · derivative · entry 10 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,012 Underlying: common shares · 36,506 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F4 · derivative.exercise_price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F4 · price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F7 · derivative.exercise_date: The restricted share units vest and will be converted to common shares in three installments: 36,506 on each of January 2, 2026, January 2, 2027 and January 2, 2028. F7 · derivative.expiration_date: The restricted share units vest and will be converted to common shares in three installments: 36,506 on each of January 2, 2026, January 2, 2027 and January 2, 2028. F9 · balance_after: This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 231,562 and 635,940 respectively. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversionrestricted share units · Derivative | 61,193 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · derivative · entry 9 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,193 Underlying: common shares · 61,193 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F4 · derivative.exercise_price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F1 · shares: Represents the conversion of vested restricted share units into common shares. F4 · price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F6 · derivative.exercise_date: The restricted share units vest and will be converted to common shares in three installments: 61,192 on January 2, 2025 and 61,193 on each of January 2, 2026 and January 2, 2027. F6 · derivative.expiration_date: The restricted share units vest and will be converted to common shares in three installments: 61,192 on January 2, 2025 and 61,193 on each of January 2, 2026 and January 2, 2027. F9 · balance_after: This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 231,562 and 635,940 respectively. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversionrestricted share units · Derivative | 62,529 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · derivative · entry 8 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 62,529 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F4 · derivative.exercise_price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F1 · shares: Represents the conversion of vested restricted share units into common shares. F4 · price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F5 · derivative.exercise_date: The restricted share units vest and will be converted to common shares in three installments: 62,528 on each of January 2, 2024 and January 2, 2025 and 62,529 on January 2, 2026. F5 · derivative.expiration_date: The restricted share units vest and will be converted to common shares in three installments: 62,528 on each of January 2, 2024 and January 2, 2025 and 62,529 on January 2, 2026. F9 · balance_after: This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 231,562 and 635,940 respectively. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Tax withholdingcommon shares | 20,188 | $36.02 | $727,171.76 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · nonDerivative · entry 7 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 635,940 F2 · shares: Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the restricted share unit transaction. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversioncommon shares | 36,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · nonDerivative · entry 6 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 656,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion of vested restricted share units into common shares. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Tax withholdingcommon shares | 33,840 | $36.02 | $1,218,916.80 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · nonDerivative · entry 5 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 619,622 F2 · shares: Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the restricted share unit transaction. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversioncommon shares | 61,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 653,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion of vested restricted share units into common shares. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Tax withholdingcommon shares | 34,859 | $36.02 | $1,255,621.18 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · nonDerivative · entry 3 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 592,269 F2 · shares: Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the restricted share unit transaction. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:24 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversioncommon shares | 62,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-000128 · marketforms-71116.xml · nonDerivative · entry 2 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 627,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion of vested restricted share units into common shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.